Spectral Medical Stock Net Asset
| SD4 Stock | EUR 0.67 0.44 39.64% |
Fundamental analysis of SPECTRAL MEDICAL allows traders to better anticipate movements in SPECTRAL MEDICAL's stock price by examining its financial health and performance throughout various phases of its business cycle.
SPECTRAL |
SPECTRAL MEDICAL Company Net Asset Analysis
SPECTRAL MEDICAL's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, SPECTRAL MEDICAL has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Diagnostics & Research (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
SPECTRAL Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SPECTRAL MEDICAL's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SPECTRAL MEDICAL could also be used in its relative valuation, which is a method of valuing SPECTRAL MEDICAL by comparing valuation metrics of similar companies.SPECTRAL MEDICAL is currently under evaluation in net asset category among its peers.
SPECTRAL Fundamentals
| Return On Equity | -7.84 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (6.38) % | |||
| Shares Outstanding | 278.22 M | |||
| Shares Owned By Insiders | 20.43 % | |||
| Shares Owned By Institutions | 13.18 % | |||
| Revenue | 1.66 M | |||
| Gross Profit | 1.22 M | |||
| EBITDA | (10.4 M) | |||
| Net Income | (2.91 M) | |||
| Cash And Equivalents | 3.43 M | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 14.70 % | |||
| Current Ratio | 6.55 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (2.19 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 31 | |||
| Beta | 1.11 | |||
| Market Capitalization | 62.12 M |
About SPECTRAL MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SPECTRAL MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SPECTRAL MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SPECTRAL MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| HLN | Haleon plc | |
| NVDA | NVIDIA | |
| INTC | Intel | |
| GFS | Globalfoundries | |
| SMCI | Super Micro Computer |
Other Information on Investing in SPECTRAL Stock
SPECTRAL MEDICAL financial ratios help investors to determine whether SPECTRAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SPECTRAL with respect to the benefits of owning SPECTRAL MEDICAL security.